Brenda Reynolds

Direktör/Styrelseledamot på

iQur Ltd.

Health Technology

Commercial Services

Process Industries

Profil

Brenda Elizabeth Reynolds is the founder of PowderMed Ltd. (founded in 2004), Convergence Pharmaceuticals Ltd. (founded in 2010), and Calchan Ltd. (founded in 2011).
She held the title of Chief Operating Officer at PowderMed Ltd. from 2004 to 2008.
Dr. Reynolds currently holds multiple non-executive director positions at iQur Ltd., D3tex Ltd., Adiga Life Sciences, Inc., BQR Consulting Ltd., and Pleco Therapeutics BV.
She is also the owner of Questrax Ltd. Dr. Reynolds received an undergraduate degree from the University of Surrey.

Aktiva positioner av Brenda Reynolds

Företag	Position	Start
iQur Ltd. iQur Ltd. BiotechnologyHealth Technology Develops vaccines	Direktör/Styrelseledamot	-
Questrax Ltd.	Företagsledare/Principal	2010-08-20
D3tex Ltd.	Direktör/Styrelseledamot	-
BQR Consulting Ltd.	Direktör/Styrelseledamot	-
Pleco Therapeutics BV Pleco Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides therapies that change the balance in the treatment of cancer	Direktör/Styrelseledamot	-

Alla aktiva positioner av Brenda Reynolds

Tidigare kända positioner av Brenda Reynolds

Företag	Position	Slut
Adiga Life Sciences, Inc. Adiga Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel immunotherapeutic products in which small components (peptides of allergen proteins are identified and administered in a regimen	Direktör/Styrelseledamot	2024-11-23
PowderMed Ltd. PowderMed Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic products	Grundare	2008-10-24
University of Birmingham Enterprise Ltd. University of Birmingham Enterprise Ltd. Investment ManagersFinance University of Birmingham Enterprise invests in companies located in the United Kingdom. The firm focuses on academic consulting services and technology service sectors. It participates financing for early stage capital transactions.	Privat kapitalinvesterare	-
Calchan Ltd. Calchan Ltd. BiotechnologyHealth Technology Operates as a biotechnology company, which develops novel oral state dependent calcium channel modulators for chronic pain	Verkställande Direktör	-
░░░ ░░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░	░░░░░░░░░░░░░░░░░░░░░░░░░	-

Se detaljerna i Brenda Reynoldss erfarenhet

Brenda Reynoldss utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Brenda Reynoldss erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	21
Pfizer Inc. Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients	Health Technology
Powderject Pharmaceuticals Plc Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Develops pharmaceutical products	Health Technology
G.D. Searle & Co., Inc. G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries Makes diversified line of chemicals and agricultural products	Process Industries
Scotia Holdings Plc Scotia Holdings Plc Miscellaneous Commercial ServicesCommercial Services Researches and develops bio-pharmaceuticals	Commercial Services
PowderMed Ltd. PowderMed Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic products	Health Technology
University of Surrey University of Surrey Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Altimmune UK Ltd. Altimmune UK Ltd. BiotechnologyHealth Technology Develops vaccines for mutating viruses	Health Technology
DC Biosciences Ltd. DC Biosciences Ltd. BiotechnologyHealth Technology Provides bioreagents and life science services	Health Technology
iQur Ltd. iQur Ltd. BiotechnologyHealth Technology Develops vaccines	Health Technology
Crescendo Biologics Ltd. Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the development of new medicines based on antibody fragment technology	Commercial Services
University of Birmingham Enterprise Ltd. University of Birmingham Enterprise Ltd. Investment ManagersFinance University of Birmingham Enterprise invests in companies located in the United Kingdom. The firm focuses on academic consulting services and technology service sectors. It participates financing for early stage capital transactions.	Finance
Questrax Ltd.
The Institute of Directors (United Kingdom) The Institute of Directors (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Operates as membership organisation that provides events, development courses, networking and expert advice	Commercial Services
Convergence Pharmaceuticals Ltd. Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops neuropathic pain products	Health Technology
Beecham Pharmaceuticals (UK)
Calchan Holdings Ltd. Calchan Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops novel oral state-dependent calcium channel (CaV 2.2) modulators for chronic pain	Health Technology
D3tex Ltd.
Adiga Life Sciences, Inc. Adiga Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel immunotherapeutic products in which small components (peptides of allergen proteins are identified and administered in a regimen	Health Technology
BQR Consulting Ltd.
Calchan Ltd. Calchan Ltd. BiotechnologyHealth Technology Operates as a biotechnology company, which develops novel oral state dependent calcium channel modulators for chronic pain	Health Technology
Pleco Therapeutics BV Pleco Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides therapies that change the balance in the treatment of cancer	Commercial Services